Genomics & Biotechnology ETF

Fund Summary

Fund Details As of 1/1/70

Key Facts

Inception Date
Bloomberg Index Ticker
Primary Exchange

Stats & Fees

Net Assets $
Shares Outstanding 0
Total Expense Ratio %


30-Day SEC Yield N/A

Fund Prices As of 1/1/70

NAV Price
Net Asset Value $ Closing Price $
Daily Change $ Daily Change $

Performance History

Cumulative %

Data as of month end (1/1/70)

Fund NAV Closing Price Index
1 Month
3 Months
6 Months
Since Inception

Avg Annualized %

Data as of month end (1/1/70)

Fund NAV Closing Price Index
1 Year
Since Inception

Cumulative %

Data as of quarter end (1/1/70)

Fund NAV Closing Price Index
Since Inception

Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized Return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted.

Top 10 Holdings

As of 1/1/70
Net Assets % Name Market Price ($) Shares Held Market Value ($)
Holdings are subject to change. Cash, where shown, includes other assets and liabilities, such as payables and receivables.

Investing involves risk, including the possible loss of principal. The investable universe of companies in which GNOM may invest may be limited. The Fund invests in securities of companies engaged in Genomics, Healthcare and Biotechnology sectors. These sectors can be affected by government regulations, rapid product obsolescence, intense industry competition and loss or impairment of patents or intellectual property rights. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. GNOM is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Global X NAVs are calculated using prices as of 4:00 PM Eastern Time. The closing price is the Mid-Point between the Bid and Ask price as of the close of exchange. Closing price returns do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Since the Fund’s shares did not trade in the secondary market until several days after the Fund’s inception, for the period from inception to the first day of secondary market trading in Shares, the NAV of the Fund is used to calculate market returns.

Carefully consider the fund’s investment objectives, risk factors, charges, and expenses before investing. This and additional information can be found in the fund’s full or summary prospectus, which may be obtained by visiting Please read the prospectus carefully before investing.